A phase 2, double-blind, placebo-controlled, multi-center, randomized study evaluating the safety and efficacy of SPRC-AB01, tobramycin solution for nasal inhalation, in post-surgical subjects with chronic sinusitis

Trial Profile

A phase 2, double-blind, placebo-controlled, multi-center, randomized study evaluating the safety and efficacy of SPRC-AB01, tobramycin solution for nasal inhalation, in post-surgical subjects with chronic sinusitis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2007

At a glance

  • Drugs Tobramycin (Primary)
  • Indications Bacterial infections; Chronic sinusitis
  • Focus Therapeutic Use
  • Sponsors Naryx Pharma
  • Most Recent Events

    • 27 Nov 2007 Patient enrolment completed.
    • 26 Nov 2007 Results expected after unblinding of data in first quarter of 2008.
    • 26 Nov 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top